Sign up to our newsletter Subscribe
An Analysis of NICE’s Optimised Decisions from 2015 to 2024

Sign up to our newsletter Subscribe
The OHE presented the following posters at ISPOR 17th Annual European Congress in Amsterdam, The Netherlands. Measuring access associated with NICE technology appraisal decisions Ispor measuring access_pon_nd from Office of Health Economics Phill O’Neill and Nancy Devlin Do NICE…
The OHE presented the following posters at ISPOR 17th Annual European Congress in Amsterdam, The Netherlands.
Measuring access associated with NICE technology appraisal decisions
Phill O’Neill and Nancy Devlin
Do NICE decisions affect decisions in other countries?
Karla Hernandez-Villafuerte, Paul Barnsley, Martina Garau and Nancy Devlin
Opportunity costs of implementing NICE decisions in NHS Wales
Sarah Karlsberg Schaffer, Jon Sussex, Dyfrig Hughes (Bangor University) and Nancy Devlin
Are the UK systems of innovation and evaluations of medical devices compatible?
Amanda Chapman, C. A. Taylor (University of Birmingham) and A. J. Girling (University of Birmingham)
A Cost-effectiveness Analysis of Interventions for Symptomatic Varicose Veins
Grace Marsden, M. Perry, A. Bradbury, N. Hickey, K. Kelley, H. Trender, D. Wonderling and A. H. Davies
What Is the Appropriate Comparator Health State to Use in Time Trade-off Studies?
Koonal Shah and Brendan Mulhern (University of Sheffield)
The Expanding Value Footprint of Oncology Treatments.
Juan Carlos Rejon-Parrilla, Karla Hernandez-Villafuerte, Koonal Shah, Jorge Mestre-Ferrandiz, Lou Garrison and Adrian Towse
An error has occurred, please try again later.